Evidence map›Paper›PMID 28332277›Full record

ArticleAmerican journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics2017

Sequencing of sporadic Attention-Deficit Hyperactivity Disorder (ADHD) identifies novel and potentially pathogenic de novo variants and excludes overlap with genes associated with autism spectrum disorder.

Daniel Seung Kim, Amber A Burt, Jane E Ranchalis, Beth Wilmot, Joshua D Smith, Karynne E Patterson, Bradley P Coe, Yatong K Li, Michael J Bamshad, Molly Nikolas and 6 more

Abstract read
In one paragraph

Article in American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Multi-omic analysis of the ciliogenic transcription factorbioRxiv : the preprint server for biology · 2025
    Article
  5. Article
  6. Review
  7. Article
  8. Toward Precision Medicine in ADHD.Frontiers in behavioral neuroscience · 2022
    Review
  9. Article
  10. Article
  11. Article
  12. MAPT haplotype-stratified GWAS reveals differential association for AD risk variants.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2020
    Article
  13. From man to fly - convergent evidence links FBXO25 to ADHD and comorbid psychiatric phenotypes.Journal of child psychology and psychiatry, and allied disciplines · 2020
    Article
  14. One Single Nucleotide Polymorphism of theDiseases (Basel, Switzerland) · 2020
    Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Frontiers in genetics · 2019
    Review
  20. Live fast, die young? A review on the developmental trajectories of ADHD across the lifespan.European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Daniel Seung KimDivision of Medical Genetics, Department of Medicine, University of Washington School of Medicine, Seattle, Washington.
Amber A BurtDivision of Medical Genetics, Department of Medicine, University of Washington School of Medicine, Seattle, Washington.
Jane E RanchalisDivision of Medical Genetics, Department of Medicine, University of Washington School of Medicine, Seattle, Washington.
Beth WilmotDivision of Bioinformatics and Computational Biology, Department of Medical Informatics and Clinical Epidemiology, Oregon Health and Science University, Portland, Oregon.
Joshua D SmithDepartment of Genome Sciences, University of Washington School of Medicine, Seattle, Washington.
Karynne E PattersonDepartment of Genome Sciences, University of Washington School of Medicine, Seattle, Washington.
Bradley P CoeDepartment of Genome Sciences, University of Washington School of Medicine, Seattle, Washington.
Yatong K LiCenter for Statistical Genetics, Department of Biostatistics, University of Michigan School of Public Health, Ann Arbor, Michigan.
Michael J BamshadDivision of Medical Genetics, Department of Medicine, University of Washington School of Medicine, Seattle, Washington.
Molly NikolasDepartment of Psychology, University of Iowa, Iowa City, Iowa.
Evan E EichlerDepartment of Genome Sciences, University of Washington School of Medicine, Seattle, Washington.
James M SwansonDepartment of Psychiatry, University of California-Irvine, Irvine, California.
Joel T NiggDepartment of Psychiatry, Oregon Health and Science University, Portland, Oregon.
Deborah A NickersonDepartment of Genome Sciences, University of Washington School of Medicine, Seattle, Washington.
Gail P JarvikDivision of Medical Genetics, Department of Medicine, University of Washington School of Medicine, Seattle, Washington.
University of Washington Center for Mendelian Genomics

Funding

UW Center for Mendelian GenomicsU54HG006493 · NHGRI · UNIVERSITY OF WASHINGTON · PI BAMSHAD, MICHAEL JOSEPH, NICKERSON, DEBORAH A · 2012 to 2015
$20.0M
University of Michigan Training Program in Genomic ScienceT32HG000040 · NHGRI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Sebastian Zoellner · 1995 to 2026
$16.4M
UW Center for Mendelian GenomicsUM1HG006493 · NHGRI · UNIVERSITY OF WASHINGTON · PI BAMSHAD, MICHAEL JOSEPH, LEAL, SUZANNE M · 2016 to 2020
$15.3M
Variation, Function, and Disease Supplement ProgramU01HG008657 · NHGRI · UNIVERSITY OF WASHINGTON · PI David Russell Crosslin, Gail Pairitz Jarvik · 2015 to 2026
$13.4M
EXPERIMENTAL PATHOLOGY OF CARDIOVASCULAR DISEASET32HL007312 · NHLBI · UNIVERSITY OF WASHINGTON · PI MAJESKY, MARK W., SCHWARTZ, STEPHEN MARK · 1985 to 2019
$11.8M
Sporadic Mutations and Autism Spectrum DisordersR01MH101221 · NIMH · UNIVERSITY OF WASHINGTON · PI EICHLER, EVAN · 2013 to 2025
$9.2M
Next Generation Mendelian GeneticsRC2HG005608 · NHGRI · UNIVERSITY OF WASHINGTON · PI BAMSHAD, MICHAEL JOSEPH, NICKERSON, DEBORAH A · 2009 to 2010
$3.9M
ADHD biotypes using genetic and imaging approachesR01MH099064 · NIMH · OREGON HEALTH & SCIENCE UNIVERSITY · PI NIGG, JOEL T · 2013 to 2017
$3.2M
Pharmacogenomics of serotonin-specific reuptake inhibitorsF31MH101905 · NIMH · UNIVERSITY OF WASHINGTON · PI KIM, DANIEL SEUNG · 2013 to 2014
$70k
NHGRI NIH HHS RC2 HG005608NHGRI NIH HHS T32 HG000040NHGRI NIH HHS U01 HG008657NHGRI NIH HHS U54 HG006493NHGRI NIH HHS UM1 HG006493NHLBI NIH HHS T32 HL007312NIMH NIH HHS F31 MH101905NIMH NIH HHS R01 MH099064NIMH NIH HHS R01 MH101221
6 · The paper itself

Abstract

Attention-Deficit Hyperactivity Disorder (ADHD) has high heritability; however, studies of common variation account for <5% of ADHD variance. Using data from affected participants without a family history of ADHD, we sought to identify de novo variants that could account for sporadic ADHD. Considering a total of 128 families, two analyses were conducted in parallel: first, in 11 unaffected parent/affected proband trios (or quads with the addition of an unaffected sibling) we completed exome sequencing. Six de novo missense variants at highly conserved bases were identified and validated from four of the 11 families: the brain-expressed genes TBC1D9, DAGLA, QARS, CSMD2, TRPM2, and WDR83. Separately, in 117 unrelated probands with sporadic ADHD, we sequenced a panel of 26 genes implicated in intellectual disability (ID) and autism spectrum disorder (ASD) to evaluate whether variation in ASD/ID-associated genes were also present in participants with ADHD. Only one putative deleterious variant (Gln600STOP) in CHD1L was identified; this was found in a single proband. Notably, no other nonsense, splice, frameshift, or highly conserved missense variants in the 26 gene panel were identified and validated. These data suggest that de novo variant analysis in families with independently adjudicated sporadic ADHD diagnosis can identify novel genes implicated in ADHD pathogenesis. Moreover, that only one of the 128 cases (0.8%, 11 exome, and 117 MIP sequenced participants) had putative deleterious variants within our data in 26 genes related to ID and ASD suggests significant independence in the genetic pathogenesis of ADHD as compared to ASD and ID phenotypes. © 2017 Wiley Periodicals, Inc.

Indexed as

Mutation, MissenseAdultAttention Deficit Disorder with HyperactivityAutism Spectrum DisorderBiomarkersChildExomeFemaleGenetic Predisposition to DiseaseHigh-Throughput Nucleotide SequencingHumansMalePhenotypeBiomarkersattention deficit hyperactivity disorder (ADHD)autism spectrum disorder (ASD)exome sequencingintellectual disability (ID)molecular inversion probe (MIP) sequencingsporadic ADHD

Identifiers

PMID28332277
PMCPMC5467442

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.